慢性阻塞性肺疾病合并高血压的研究进展

Advances in the Study of Chronic Obstructive Pulmonary Disease in Combination with Hypertension

摘要: 全球慢性病发病与死亡最主要的部分是有极高发病率与病死率的慢性阻塞性肺疾病。慢阻肺合并高血压非常常见，对慢阻肺患者的急性发病率、生存率、死亡率、日常生存质量都有着重大影响。通过对慢阻肺合并高血压的最新研究进行综述，发现慢阻肺合并高血压的发病机制主要是全身性炎症改变，而目前在慢阻肺的疾病管理策略中，对于如何干预高血压影响慢阻肺的措施并没有明确说明。在临床诊疗和研究中需要注意对慢阻肺合并高血压患者的评估与管理，掌握慢阻肺与高血压之间的发病机制，明确慢阻肺合并高血压患者的治疗与管理，有助于慢性阻塞性肺疾病合并高血压患者的病情控制及预后。

Abstract: The most significant part of global chronic disease morbidity and mortality is COPD, which has a very high morbidity and mortality rate. Chronic obstructive pulmonary disease combined with hy-pertension is very common and has a significant impact on acute morbidity, survival, mortality and the quality of daily life of patients with chronic obstructive pulmonary disease. A review of recent studies on hypertension in combination with slow-onset lung reveals that the pathogenesis of hy-pertension in combination with slow-onset lung is mainly systemic inflammatory changes, and there is currently no clear description of how to intervene in the disease management strategy of slow-onset lung for hypertension affecting slow-onset lung. The assessment and management of pa-tients with chronic obstructive pulmonary disease combined with hypertension need to be paid at-tention to in clinical diagnosis and research, to grasp the pathogenesis between chronic obstructive pulmonary disease and hypertension, and to clarify the treatment and management of patients with chronic obstructive pulmonary disease combined with hypertension, which can help the dis-ease control and prognosis of patients with chronic obstructive pulmonary disease combined with hypertension.